• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脊索瘤的骨转移:影像学与临床发现

Osseous metastases of chordoma: imaging and clinical findings.

作者信息

Chang Connie, Chebib Ivan, Torriani Martin, Bredella Miriam

机构信息

Division of Musculoskeletal Imaging and Intervention, Department of Radiology, Massachusetts General Hospital, 55 Fruit Street Yawkey 6E, Boston, MA, 02114, USA.

Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.

出版信息

Skeletal Radiol. 2017 Mar;46(3):351-358. doi: 10.1007/s00256-016-2566-5. Epub 2017 Jan 7.

DOI:10.1007/s00256-016-2566-5
PMID:28064345
Abstract

PURPOSE

To describe the imaging and clinical characteristics of chordoma osseous metastases (COM).

MATERIALS AND METHODS

Our study was IRB approved and HIPAA compliant. A retrospective search of our pathology database for pathology-proven COM yielded 15 patients who had undergone MRI, CT, bone scan, and/or FDG-PET/CT. The imaging and clinical features of the COMs were recorded. A control group of age and gender matched chordoma patients without osseous metastasis was evaluated.

RESULTS

The COM mean maximal dimension was 6.4 ± 4.0 cm. The majority (60%) of patients had one lesion. Extra-osseous soft tissue component was present in 85% and was larger than intra-osseous component in 76%. On MRI the lesions were heterogeneous but predominantly T2 hyperintense with hypointense septae, and with variable enhancement. On CT the lesions were typically destructive or permeative; calcifications were rare. The extent of the soft tissue component was isodense to muscle on CT and therefore better evaluated on MRI. COM was in a body part contiguous to the site of the primary tumor. Compared to the controls, COM patients were more likely to have local recurrence (P = 0.0009) and positive resection margins (P = 0.002). At 1 year, 33% of COM patients were deceased and 13% had progressive metastases.

CONCLUSION

COM are associated with large extra-osseous soft tissue components, which are better visualized by MRI. They are often located in a body part contiguous to the site of the primary tumor, portend poor prognosis, and are associated with positive resection margins and local recurrence.

摘要

目的

描述骨转移性脊索瘤(COM)的影像学和临床特征。

材料与方法

本研究经机构审查委员会(IRB)批准并符合健康保险流通与责任法案(HIPAA)规定。对我们的病理数据库进行回顾性检索,以查找经病理证实的COM患者,共纳入15例接受过MRI、CT、骨扫描和/或FDG-PET/CT检查的患者。记录COM的影像学和临床特征。对一组年龄和性别匹配的无骨转移的脊索瘤患者作为对照组进行评估。

结果

COM的平均最大径为6.4±4.0 cm。大多数(60%)患者有一个病灶。85%的患者存在骨外软组织成分,其中76%的患者骨外软组织成分大于骨内成分。在MRI上,病灶表现为不均匀信号,但主要为T2高信号,伴有低信号分隔,增强方式多样。在CT上,病灶通常表现为破坏性或浸润性;钙化少见。软组织成分在CT上与肌肉密度相等,因此在MRI上能更好地评估。COM位于与原发肿瘤部位相邻的身体部位。与对照组相比,COM患者更易出现局部复发(P = 0.0009)和手术切缘阳性(P = 0.002)。1年时,33%的COM患者死亡,13%有进行性转移。

结论

COM与较大的骨外软组织成分相关,MRI能更好地显示这些成分。它们常位于与原发肿瘤部位相邻的身体部位,预后不良,且与手术切缘阳性和局部复发相关。

相似文献

1
Osseous metastases of chordoma: imaging and clinical findings.脊索瘤的骨转移:影像学与临床发现
Skeletal Radiol. 2017 Mar;46(3):351-358. doi: 10.1007/s00256-016-2566-5. Epub 2017 Jan 7.
2
Comparison of CE-FDG-PET/CT with CE-FDG-PET/MR in the evaluation of osseous metastases in breast cancer patients.对比CE-FDG-PET/CT与CE-FDG-PET/MR在评估乳腺癌患者骨转移方面的效果。
Br J Cancer. 2015 Apr 28;112(9):1452-60. doi: 10.1038/bjc.2015.112. Epub 2015 Apr 14.
3
Metastatic myxoid liposarcomas: imaging and histopathologic findings.转移性黏液样脂肪肉瘤:影像学及组织病理学表现
Skeletal Radiol. 2008 Mar;37(3):251-8. doi: 10.1007/s00256-007-0424-1. Epub 2007 Dec 21.
4
Imaging features of phosphaturic mesenchymal tumors.磷酸尿性间叶肿瘤的影像学特征。
Skeletal Radiol. 2019 Jan;48(1):119-127. doi: 10.1007/s00256-018-3014-5. Epub 2018 Jul 9.
5
Characterization of Metastatic Sternal Lesions on Dynamic Contrast-Enhanced Breast MRI in Women with Invasive Breast Cancer.女性浸润性乳腺癌动态对比增强乳腺 MRI 中转移性胸骨病变的特征。
Acad Radiol. 2019 Oct;26(10):1358-1362. doi: 10.1016/j.acra.2018.11.011. Epub 2018 Dec 5.
6
"One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?一站式分期:我们应该更倾向于使用 FDG-PET/CT 还是 MRI 来检测骨转移?
Eur J Radiol. 2011 Jun;78(3):430-5. doi: 10.1016/j.ejrad.2009.10.031. Epub 2009 Nov 27.
7
Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtype.乳腺癌未经治疗的骨转移灶在氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描(FDG PET/CT)上的表现:组织学亚型的重要性
Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1666-1673. doi: 10.1007/s00259-015-3080-z. Epub 2015 May 14.
8
[18F]-Fluoromisonidazole positron emission tomography/computed tomography visualization of tumor hypoxia in patients with chordoma of the mobile and sacrococcygeal spine.[18F] - 氟米索硝唑正电子发射断层扫描/计算机断层扫描对活动期和骶尾椎脊索瘤患者肿瘤缺氧情况的可视化
Int J Radiat Oncol Biol Phys. 2014 Dec 1;90(5):1030-6. doi: 10.1016/j.ijrobp.2014.08.016.
9
FDG PET/CT for bone and soft-tissue biopsy.用于骨与软组织活检的氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描(FDG PET/CT)
Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1333-4. doi: 10.1007/s00259-015-3017-6. Epub 2015 Feb 19.
10
Is methylene diphosphonate bone scan necessary for initial staging of Ewing sarcoma if 18F-FDG PET/CT is performed?如果进行 18F-FDG PET/CT 检查,是否有必要对尤文肉瘤进行初始分期时行亚甲基二膦酸盐骨扫描?
AJR Am J Roentgenol. 2014 Apr;202(4):859-67. doi: 10.2214/AJR.13.11239.

引用本文的文献

1
Muscle metastasis from cervical chordoma: a case report.颈椎脊索瘤的肌肉转移:一例报告
Skeletal Radiol. 2025 Jun;54(6):1331-1336. doi: 10.1007/s00256-024-04780-7. Epub 2024 Sep 11.
2
Immunophenotypic features of dedifferentiated skull base chordoma: An insight into the intratumoural heterogeneity.去分化颅底脊索瘤的免疫表型特征:对肿瘤内异质性的深入了解
Contemp Oncol (Pozn). 2017;21(4):267-273. doi: 10.5114/wo.2017.72385. Epub 2017 Dec 30.
3
Multifocal metastatic chordoma to the soft tissues of the fingertips: a case report including sonographic features and a review of the literature.

本文引用的文献

1
Characteristics and Patterns of Metastatic Disease from Chordoma.脊索瘤转移疾病的特征与模式
Sarcoma. 2015;2015:517657. doi: 10.1155/2015/517657. Epub 2015 Dec 30.
2
Metastatic Chordoma: Report of the Two Cases and Review of the Literature.转移性脊索瘤:两例报告及文献复习
Eurasian J Med. 2015 Jun;47(2):151-4. doi: 10.5152/eurasianjmed.2015.52.
3
Combined therapy for distant metastasis of sacral chordoma.骶骨脊索瘤远处转移的联合治疗
指尖软组织多灶性转移性脊索瘤:一例报告,包括超声特征及文献复习
Skeletal Radiol. 2018 Mar;47(3):401-406. doi: 10.1007/s00256-017-2785-4. Epub 2017 Oct 7.
Case Rep Surg. 2015;2015:165162. doi: 10.1155/2015/165162. Epub 2015 Jan 11.
4
Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases.99m-Tc-MDP骨闪烁显像与18F-FDG PET/CT检测骨转移瘤的诊断准确性比较
Acta Radiol. 2016 Jan;57(1):58-65. doi: 10.1177/0284185114564438. Epub 2014 Dec 22.
5
Role of 18F-FDG PET-CT in the study of sacrococcygeal chordoma.18F-FDG PET-CT在骶尾部脊索瘤研究中的作用
Rev Esp Med Nucl Imagen Mol. 2012 Nov-Dec;31(6):359-61. doi: 10.1016/j.remn.2011.11.001. Epub 2011 Dec 19.
6
Imaging characteristics of metastatic chordoma.转移性脊索瘤的影像学特征。
Jpn J Radiol. 2012 Jul;30(6):509-16. doi: 10.1007/s11604-012-0086-3. Epub 2012 May 18.
7
Chordoma: current concepts, management, and future directions.脊索瘤:当前概念、管理和未来方向。
Lancet Oncol. 2012 Feb;13(2):e69-76. doi: 10.1016/S1470-2045(11)70337-0.
8
Classic chordoma coexisting with benign notochordal cell rest demonstrating different immunohistological expression patterns of brachyury and galectin-3.经典脊索瘤与良性脊索细胞残余并存,表现出不同的 brachyury 和半乳糖凝集素-3 的免疫组织化学表达模式。
J Clin Neurosci. 2011 Jan;18(1):96-9. doi: 10.1016/j.jocn.2010.03.066. Epub 2010 Sep 19.
9
Lumbar vertebral chordoma arising from an intraosseous benign notochordal cell tumour: radiological findings and histopathological description with a good clinical outcome.源自骨内良性脊索瘤细胞肿瘤的腰椎脊索瘤:影像学表现和组织病理学描述,临床预后良好。
Br J Radiol. 2010 Mar;83(987):e49-53. doi: 10.1259/bjr/63846600.
10
Cervical chordoma in childhood without typical vertebral bony destruction: case report and review of the literature.儿童期无典型椎体骨质破坏的颈椎脊索瘤:病例报告及文献复习
Spine (Phila Pa 1976). 2009 Jun 15;34(14):E493-7. doi: 10.1097/BRS.0b013e3181a8ced8.